Trial Profile
A multicenter randomized double-masked comparative study of different preparations of alendronate in osteoporosis – monthly (four weeks) intravenous versus once weekly oral administrations
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Aug 2012
Price :
$35
*
At a glance
- Drugs Alendronic acid (Primary) ; Alendronic acid (Primary)
- Indications Osteoporosis; Postmenopausal osteoporosis
- Focus Biomarker; Therapeutic Use
- 23 Aug 2012 New trial record